Human Xt-M (HUMX.M) AI Stock Analysis

Human Xt-M

(TASE:HUMX.M)

Select Model

Rating:50Neutral

Price Target:ILA 23.50▼(-73.89% Downside)

Action:initiatedcoverage

Date:01/13/26

Dominated by poor financials (revenue collapse, losses, cash drain) pulling score down; partially offset by reasonable valuation for a distressed growth play and neutral technicals with low volatility.

Positive Factors

Very low leverageZero reported debt materially reduces refinancing and interest-rate risk and preserves financial optionality. Over a 2–6 month horizon this strengthens the firm's ability to negotiate restructuring, access capital markets if needed, and prioritize operational fixes without immediate debt-service pressure.

Negative Factors

Sharp 2024 revenue collapse and negative gross profitA ~74% revenue drop paired with negative gross profit indicates unit economics are broken and costs exceed sales. Structurally, this undermines margin sustainability and means simple volume recovery alone won’t restore profitability; durable remediation requires major cost or business-model changes.

Human Xt-M (HUMX.M) vs. iShares MSCI Israel ETF (EIS)

Market Cap: ILS 8.72M
Dividend Yield: ―
Average Volume (3M): 7,211
Price to Earnings (P/E): -0.4
Beta (1Y): 0.37
Revenue Growth: -100.00%
EPS Growth: 62.02%
Country: Israel
Employees: 21
Sector: General
Sector Strength: 55
Industry: Medical - Devices

Human Xt-M Business Overview & Revenue Model

Company Description

Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monopola...

Human Xt-M Financial Statement Overview

Summary

Severe distress with 87% revenue plunge, negative gross margins, ballooning net losses, heavy cash burn, and 98% equity erosion despite debt elimination; highlights operational volatility and liquidity risks in devices sector.

Income Statement

12Very Negative

Balance Sheet

45Neutral

Cash Flow

8Very Negative

Human Xt-M Technical Analysis

Technical Analysis SentimentNegative

Last Price90.00

Price Trends

50DMA134.97Negative

100DMA161.59Negative

200DMA175.32Negative

Market Momentum

MACD-12.06Positive

RSI3.70Positive

STOCH100.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HUMX.M, the sentiment is Negative. The current price of 90.00 is below the 20-day moving average (MA) of 119.70, below the 50-day MA of 134.97, and below the 200-day MA of 175.32, indicating a bearish trend. The MACD of -12.06 indicates Positive momentum. The RSI at 3.70 is Positive, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HUMX.M.

Human Xt-M Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IL:HUMX.M against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IL:BWAY	78Outperform	ILS 1.50B	49.16	10.95%	―	14.06%	44.16%
IL:SOFW	76Outperform	ILS 1.32B	45.65	―	―	30.12%	―
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IL:HUMX.M	50Neutral	ILS 2.41M	-0.40	―	―	-100.00%	62.02%

* General Sector Average

Performance Comparison

IL:HUMX.M and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IL:HUMX.M	Human Xt-M	90.00	-151.00	-62.66%
IL:BWAY	Brainsway	3500.00	727.00	26.22%
IL:ILX	ILEX Medical Ltd.	4827.00	-1556.05	-24.38%
IL:ALMD	Allmed Solutions Ltd.	31.10	-0.70	-2.20%
IL:EPIT	EPITOMEE MEDICAL LTD	348.50	-425.80	-54.99%
IL:SOFW	Sofwave Medical Ltd.	3422.00	272.00	8.63%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jan 27, 2026

Human Xt-M AI Stock Analysis